Being rejected in early 2022, Elon Musk's brain-implant initiative, Neuralink, has finally managed to secure FDA's approval. Thanks to this step, the road to the first-in-human clinical trial is now o
pen. Recruitment is not open yet, but more information on this matter should become available soon. ...